NCT00100334

Data

{
  "briefSummary": "This is a single-center, double-blind, inpatient study followed by an outpatient, placebo-controlled, multiple-IV injection evaluation of the safety and tolerability of PPI-1019 in subjects with mild-moderate Alzheimer's disease (AD). The primary objective of the study is to assess the safety of multiple IV injections of PPI-1019 in subjects with mild-moderate Alzheimer's disease.",
  "completionDate": "2005-08",
  "conditions": [
    "Alzheimer's Disease"
  ],
  "enrollmentCount": 24,
  "enrollmentType": null,
  "nctId": "NCT00100334",
  "phase": "PHASE1, PHASE2",
  "sponsorId": "praecis-pharmaceuticals-inc",
  "startDate": "2004-12",
  "status": "COMPLETED",
  "studyType": "INTERVENTIONAL",
  "title": "Multiple Dose Safety and Preliminary Pharmacodynamic Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease",
  "url": "https://clinicaltrials.gov/study/NCT00100334"
}

History in this collection

1. addedv1.0.0Jun 12, 2026this version